NCT00316550View on ClinicalTrials.gov

Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

September 30, 2007

Conditions
Irritable Bowel Syndrome (IBS)
Interventions
DRUG

AV608

Trial Locations (1)

90095

UCLA Center for Neurovisceral Sciences and Women's Health, Los Angeles

Sponsors
All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

Avera Pharmaceuticals

INDUSTRY

NCT00316550 - Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter